These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26546263)

  • 1. Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis.
    Kosmidis C; Powell G; Borrow R; Morris J; Alachkar H; Denning DW
    Vaccine; 2015 Dec; 33(51):7271-7275. PubMed ID: 26546263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children.
    Quezada A; Maggi L; Norambuena X; Inostroza J; Quevedo F
    Allergol Immunopathol (Madr); 2016; 44(4):376-81. PubMed ID: 27255476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections.
    van Kessel DA; Hoffman TW; van Velzen-Blad H; Zanen P; Rijkers GT; Grutters JC
    Clin Exp Immunol; 2014 Jul; 177(1):272-9. PubMed ID: 24547957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional immune responses to twelve serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults.
    Ahn JG; Kim HW; Choi HJ; Lee JH; Kim KH
    Vaccine; 2015 Sep; 33(38):4770-5. PubMed ID: 26277073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
    McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
    Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary disease.
    Lai CC; Lee LN; Yu CJ; Hsueh PR; Yang PC; Kuo SH; Luh KT
    J Formos Med Assoc; 2007 Mar; 106(3):196-203. PubMed ID: 17389163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG levels against 13-valent pneumococcal conjugate vaccine serotypes in non pneumococcal conjugate vaccine immunized healthy Japanese and intravenous immunoglobulin preparations.
    Takahashi Y; Ishiwada N; Hishiki H; Tanaka J; Akeda Y; Shimojo N; Oishi K; Kohno Y
    J Infect Chemother; 2014 Dec; 20(12):794-8. PubMed ID: 25242584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
    Parker AR; Park MA; Harding S; Abraham RS
    Vaccine; 2019 Feb; 37(10):1350-1355. PubMed ID: 30737041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the 23-valent pneumococcal vaccine protect cochlear implant recipients?
    Hey C; Rose MA; Kujumdshiev S; Gstoettner W; Schubert R; Zielen S
    Laryngoscope; 2005 Sep; 115(9):1586-90. PubMed ID: 16148699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination.
    Menon VJ; Corscadden KJ; Fuery A; Thornton RB; Kirkham LA; Richmond PC; Wiertsema SP
    Vaccine; 2012 Apr; 30(20):3136-44. PubMed ID: 22326775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.
    Prins-van Ginkel AC; Berbers GA; Grundeken LH; Tcherniaeva I; Wittenberns JI; Elberse K; Mollema L; de Melker HE; Knol MJ
    PLoS One; 2016; 11(1):e0147437. PubMed ID: 26796783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients.
    Lu CL; Hung CC; Chuang YC; Liu WC; Su CT; Hsiao CF; Tseng YT; Su YC; Chang SF; Chang SY; Chang SC
    Vaccine; 2012 May; 30(24):3526-33. PubMed ID: 22484349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis.
    Harrison E; Singh A; Morris J; Smith NL; Fraczek MG; Moore CB; Denning DW
    Int J Immunogenet; 2012 Jun; 39(3):224-32. PubMed ID: 22225939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals.
    Nived P; Jørgensen CS; Settergren B
    Vaccine; 2015 Mar; 33(14):1688-94. PubMed ID: 25707692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal-specific IgG levels after 13-valent pneumococcal conjugate vaccination in Nigerian children with sickle cell disease.
    Disu EA; Akodu SO; Arinola OG; Diaku-Akinwumi IN; Adedokun B; Olopade CO; Njokanma OF
    Paediatr Int Child Health; 2016 Nov; 36(4):296-299. PubMed ID: 26745438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study.
    Fischer L; Gerstel PF; Poncet A; Siegrist CA; Laffitte E; Gabay C; Seebach JD; Ribi C
    Arthritis Res Ther; 2015 Jun; 17(1):151. PubMed ID: 26048579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.